Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 12/31/2020 (updated monthly) $1,537.8 (M)
Net Assets - Class C As of 01/31/2021 (updated monthly) $68.9 (M)

Positions As of 01/31/2021

Equity VS. NASDAQ Biotechnology Index

Fund Benchmark
Market CapitalizationAs of 01/31/2021 (updated monthly) $27,728.37(M) $39,130.86(M)
P/B RatioAs of 01/31/2021 (updated monthly) 6.16 6.45
P/E Ratio (12-mo Forward)As of 01/31/2021 (updated monthly) 17.27 16.67
Price to Cash FlowAs of 01/31/2021 (updated monthly) 18.29 18.68

Portfolio Details

Asset AllocationAs of 01/31/2021

[name] [value]
Equity 95.76%
Cash & Cash Equivalents 4.24%

Geographic BreakdownAs of 01/31/2021

[name] [value]
United States 84.27%
United Kingdom 4.77%
Cash & Cash Equivalents 4.24%
Denmark 2.17%
Canada 2.05%
Switzerland 1.40%
Netherlands 1.10%

sector breakdownAs of 01/31/2021

[name] [value]
Biotechnology 76.58%
Pharmaceuticals 13.12%
Life Sciences Tools & Services 4.55%
Cash & Cash Equivalents 4.24%
Diversified Capital Markets 1.26%
Other Diversified Financial Services 0.25%

TOP TEN HOLDINGSAs of 01/31/2021

Issuer Country Industry % of total
GILEAD SCIENCES INC United States Pharmaceuticals, Biotechnology & Life Sciences 6.42%
VERTEX PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.45%
REGENERON PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.05%
AMGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.98%
ILLUMINA INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.55%
GW PHARMACEUTICALS PLC United Kingdom Pharmaceuticals, Biotechnology & Life Sciences 4.54%
IOVANCE BIOTHERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.96%
NOVAVAX INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.32%
PTC THERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 2.87%
BIOGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 2.69%

Market Capitalization BreakdownAs of 01/31/2021

[name] [value]
<2.0 Billion 22.03%
2.0-5.0 Billion 18.36%
5.0-10.0 Billion 14.87%
10.0-25.0 Billion 11.49%
25.0-50.0 Billion 5.42%
>50.0 Billion 27.63%
N/A 0.21%